95 related articles for article (PubMed ID: 6292759)
21. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
Gregoratti L; Redaelli G; Limido P; Ghiringhelli L
Clin Ter; 1982 Sep; 102(6):607-19. PubMed ID: 6291844
[No Abstract] [Full Text] [Related]
22. Intermittent claudication: Suloctidil v.s. placebo treatment.
Holm J; Lindblad L; Scherstén T; Suurkula M
Vasa; 1984; 13(2):175-8. PubMed ID: 6331019
[No Abstract] [Full Text] [Related]
23. Hypocholesterolaemic activity of suloctidil: double-blind, crossover short-term and long-term treatment trial.
Chieffo C; Postiglione A; Tritto C; Mancini M
Curr Med Res Opin; 1984; 9(3):147-52. PubMed ID: 6094103
[TBL] [Abstract][Full Text] [Related]
24. Atherosclerotic cerebrovascular disease: significance.
Jacob JC
Int Anesthesiol Clin; 1984; 22(3):3-10. PubMed ID: 6480134
[No Abstract] [Full Text] [Related]
25. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study.
Shin DH; Lee PH; Bang OY
Arch Neurol; 2005 Aug; 62(8):1232-7. PubMed ID: 16087764
[TBL] [Abstract][Full Text] [Related]
26. Combination of suloctidil and anticoagulation in the prevention of reocclusion after femoro-popliteal PTA.
Mahler F; Schneider E; Gallino A; Bollinger A
Vasa; 1987; 16(4):381-5. PubMed ID: 2827398
[No Abstract] [Full Text] [Related]
27. Activation of platelets and of fibrinolysis by venous occlusion in healthy volunteers and influence of suloctidil in comparison with placebo.
Baele G; Bary JL; van Stalle F
Arzneimittelforschung; 1983; 33(8):1203-5. PubMed ID: 6315025
[TBL] [Abstract][Full Text] [Related]
28. Nootropics: status and prospects.
Itil TM
Biol Psychiatry; 1983 May; 18(5):521-3. PubMed ID: 6305429
[No Abstract] [Full Text] [Related]
29. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Spinella G; Majorana M
Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
[No Abstract] [Full Text] [Related]
30. Antithrombotic activity of suloctidil.
Roba J; Defreyn G; Biagi G
Thromb Res Suppl; 1983; 4():53-8. PubMed ID: 6314585
[No Abstract] [Full Text] [Related]
31. [Effect of suloctidil on the contractions of isolated rat aortic strips induced by norepinephrine and CaCl2].
Ishibashi A; Hanagata R; Horii D; Hisayama T; Takayanagi I
Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):361-73. PubMed ID: 6323288
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
Lefebvre P; Crocq L; Bernard JG
Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
[No Abstract] [Full Text] [Related]
33. Studies of suloctidil in experimental thrombosis in baboons.
Hanson SR; Harker LA
Thromb Haemost; 1985 Jun; 53(3):423-7. PubMed ID: 2996168
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and immunologic comparison in chronic ischemic brain disease secondary to atherosclerosis].
Martynova GI
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; (Suppl 2):40-4. PubMed ID: 12830529
[TBL] [Abstract][Full Text] [Related]
35. Effect of suloctidil on cerebral circulation patterns of conscious rabbits.
Rozza Dionigi A; Lanza E; Favalli L; Carminati GM; Piccinini F
Arzneimittelforschung; 1986 Feb; 36(2):194-6. PubMed ID: 3008769
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of early dynamic changes of intracranial arterial occlusion is useful for stroke etiology diagnosis.
Cho AH; Kwon SU; Kim JS; Kang DW
J Neurol Sci; 2012 Jan; 312(1-2):127-30. PubMed ID: 21872274
[TBL] [Abstract][Full Text] [Related]
37. [Current treatment of cerebrovascular disorder with vasoactive drugs].
Lebiediewa NW
Neurol Neurochir Pol; 1981; 15(4):417-21. PubMed ID: 6895779
[TBL] [Abstract][Full Text] [Related]
38. [Anginin effect in cerebovascular disorders in the light of psychological studies].
Michalska I
Neurol Neurochir Pol; 1979; 13(2):141-6. PubMed ID: 377119
[TBL] [Abstract][Full Text] [Related]
39. Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis.
Gerin J
Br J Clin Pract; 1974 May; 28(5):177-8. PubMed ID: 4604345
[No Abstract] [Full Text] [Related]
40. A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke.
Gent M; Blakely JA; Hachinski V; Roberts RS; Barnett HJ; Bayer NH; Carruthers SG; Collins SM; Gawel MG; Giroux-Klimek M
Stroke; 1985; 16(3):416-24. PubMed ID: 2988158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
